◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Home › All stocks › 0-9 › 1276

Jiangsu Hengrui Pharmaceuticals Co.,Ltd (1276) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-11

Jiangsu Hengrui Pharmaceuticals Co.,Ltd (1276) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Lianyungang, China with about 20,602 employees. Its market capitalization is roughly CNY 382 billion. In the fiscal year ended 2025-12-31, 1276 reported CNY 31.6B in revenue and CNY 7.7B in net income.

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally.

Interactive charts & full statements →

1276 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-31
Total RevenueCNY 31.6BCNY 28.0BCNY 22.8BCNY 21.3B
Gross ProfitCNY 27.3BCNY 24.1BCNY 19.3BCNY 17.8B
Operating Income (EBIT)CNY 8.6BCNY 6.8BCNY 4.6BCNY 3.3B
Net IncomeCNY 7.7BCNY 6.3BCNY 4.3BCNY 3.9B

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

1276 Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-06-302025-03-312024-12-31
Total RevenueCNY 8.1BCNY 8.4BCNY 8.6BCNY 7.2BCNY 7.8B
Gross ProfitCNY 7.0BCNY 7.3BCNY 7.5BCNY 6.1BCNY 6.8B
Operating Income (EBIT)CNY 2.6BCNY 2.3BCNY 2.8BCNY 2.0BCNY 1.9B
Net IncomeCNY 2.3BCNY 2.0BCNY 2.6BCNY 1.9BCNY 1.7B

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

1276 Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-312021-12-31
Dividends Paid(CNY 1.3B)(CNY 1.3B)(CNY 1.0B)(CNY 1.0B)—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

1276 Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-03-312025-12-312025-06-302025-03-312024-12-31
Dividends Paid—(CNY 10M)——CNY 0M

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

1276 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-31
Total AssetsCNY 69.9BCNY 50.1BCNY 43.8BCNY 42.4B
Total LiabilitiesCNY 8.1BCNY 4.0BCNY 2.8BCNY 4.0B

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 1276 viewer.

1276 Metric Deep Dives

Other Companies in Drug Manufacturers - Specialty & Generic

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← 1274All “0-9” companies1277 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.